BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2668502)

  • 1. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
    Wong PC; Price WA; Reilly TM; Duncia JV; Timmermans PB
    J Pharmacol Exp Ther; 1989 Aug; 250(2):515-22. PubMed ID: 2668502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the functional antagonism and antihypertensive activity displayed by a monoclonal antibody to angiotensin II.
    Reilly TM; Wong PC; Price WA; Timmermans PB
    J Pharmacol Exp Ther; 1988 Jan; 244(1):160-5. PubMed ID: 3275771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307).
    Wong PC; Chiu AT; Price WA; Thoolen MJ; Carini DJ; Johnson AL; Taber RI; Timmermans PB
    J Pharmacol Exp Ther; 1988 Oct; 247(1):1-7. PubMed ID: 3171969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive rat.
    Lee JY; Buckner SA; Brune ME; Warner RB; Winn M; De B; Zydowsky TM; Opgenorth TJ; Kerkman DJ; Debernardis JF
    J Pharmacol Exp Ther; 1994 Jan; 268(1):427-33. PubMed ID: 8301584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
    Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
    J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
    Chiu AT; Duncia JV; McCall DE; Wong PC; Price WA; Thoolen MJ; Carini DJ; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1989 Sep; 250(3):867-74. PubMed ID: 2778716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
    Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
    J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
    Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
    Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
    Edwards RM; Aiyar N; Ohlstein EH; Weidley EF; Griffin E; Ezekiel M; Keenan RM; Ruffolo RR; Weinstock J
    J Pharmacol Exp Ther; 1992 Jan; 260(1):175-81. PubMed ID: 1309870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
    J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
    Hajj-Ali AF; Reilly TM; Wong PC
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1152-7. PubMed ID: 7932165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.